Manuel Carbonell: Modern Phlebology Should Not Be a Competition of Devices and Technology
Manuel Carbonell, Director at the Center of Phlebology, shared a post on LinkedIn:
” ‘Sclerotherapy begins and ends phlebology.’
– John Bergan
Today I would like to share a clinical case that reflects something that is still often underestimated within our specialty:
Ultrasound-guided foam sclerotherapy: the ‘Cinderella’ of phlebology
Patient with chronic venous insufficiency treated with ultrasound-guided foam sclerotherapy using 5% polidocanol.
Technique:
- 5% polidocanol
- Total of 12cc of foam
- 6cc injected at 10 cm of the saphenofemoral junction
- 6cc injected at the distal third of the thigh
The post-treatment image corresponds to the first week follow-up.
Clinical evolution:
- No significant pain
- No need for anti-inflammatory medication
- Excellent tolerance
- Marked symptom reduction
- Very satisfied patient
At a time when so much attention is focused exclusively on thermal technologies and increasingly sophisticated devices, it is worth remembering that ultrasound-guided foam sclerotherapy remains, in experienced hands and with proper patient selection, an extraordinarily valuable tool.
Modern phlebology should not become a competition of devices and technology, but rather the art of choosing the right treatment for the right anatomy and the right patient.
Ultrasound-guided foam still offers important advantages:
- Minimally invasive
- Rapid recovery
- Very low post-procedural pain
- Repeatable when necessary
- Significantly lower costs
- Excellent tolerance in selected patients
Probably the ‘Cinderella’ of phlebology… yet often one of the most elegant and efficient tools we have.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026